The More Life Company Corp. (the “Company”) (CSE: MLCO) formerly Mountain Valley MD Holdings Inc., further to its press release dated August 18, 2026 announcing the completion of its corporate name change, is pleased to announce that its common shares will continue to be quoted on the OTCID under the new trading symbol “TMLCF”, effective at the opening of trading on August 21, 2026.
The Company commenced trading on the Canadian Securities Exchange under its new name and trading symbol “MLCO” on August 20, 2026. The Company’s new CUSIP number is 616536108 and its new ISIN is CA6165361081.
ABOUT THE MORE LIFE COMPANY CORP.
The More Life Company Corp. is a life sciences company focused on commercializing proprietary and licensed technologies for agriculture and human health. The technologies are designed to support crop productivity and resilience and to improve the formulation, stability and delivery of selected active ingredients.
In agriculture, the Company is advancing Agrarius™, a licensed biological plant-signaling technology designed to support crop yield, resilience and more efficient use of agricultural inputs.
In human health, the Company is advancing its patented Quicksome™ oral formulation and delivery technology. Quicksome™ uses proprietary formulations and stabilizing molecules to encapsulate active ingredients into product formats designed to improve their delivery, stability and performance. The Company is pursuing applications across nutraceutical, pharmaceutical and compounding markets.
The Company’s patented Quicksol™ technology is designed to improve the solubility of macrocyclic lactones and support their potential use across a range of human and animal health applications.
Through its technologies, commercial relationships and scientific development programs, The More Life Company is working to translate biological innovation into measurable real-world performance.
For more information, visit www.themorelife.company.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION
Certain statements contained in this news release may constitute forward-looking information within the meaning of applicable securities laws. Forward-looking information is often, but not always, identified by words such as “anticipate”, “believe”, “continue”, “estimate”, “expect”, “intend”, “may”, “plan”, “potential”, “should”, “will” and similar expressions, or statements that events, conditions or results “can”, “could”, “may”, “should” or “will” occur or be achieved.
The forward-looking information contained in this news release includes, without limitation, statements regarding the expected timing for the Company’s common shares to trade on the OTCID under the new trading symbol “TMLCF” effective at the opening of trading on August 21, 2026.
The anticipated effective date and trading symbol change are subject to the timing and completion of applicable OTC Markets Group and other administrative processes and may differ from the date currently expected by the Company. Although the Company believes that the expectations and assumptions reflected in the forward-looking information are reasonable as of the date hereof, forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause actual timing, results or outcomes to differ materially from those expressed or implied by such forward-looking information.
Readers are cautioned not to place undue reliance on forward-looking information. Any forward-looking information contained in this news release represents the Company’s expectations as of the date hereof and is subject to change after such date. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities legislation.
Neither the CSE nor OTC Markets Group has reviewed or approved the contents of this press release.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260820259472/en/
Media gallery
